Benjamin Oakes

Benjamin Oakes serves as Chief Executive Officer at Scribe Therapeutics. Scribe Therapeutics operates in the research sector with approximately 120.0 employees. The company is headquartered in Berkeley, California. Scribe Therapeutics generates annual revenue of 2500000.0. To date, Scribe Therapeutics has raised 120000000.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Scribe Therapeutics.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Sendgrid Gmail Outlook Google Apps Microsoft Office 365 Amazon AWS Greenhouse.io WP Engine Vimeo Nginx WordPress.org Mobile Friendly Viewpoint

biotechnology research crispr genetic medicines gene editing epigenetic silencing crispr by design molecular engineering therapeutic targets cardiometabolic disease genetic therapy in vivo editing portfolio of treatments off-target effects safety potency pcsk9 ldl-c genomic diseases collaborations biopharmaceutical clinical development gene therapy chronic disease precision medicine potency & safety genetics genetic modification crispr systems nobel prize innovative delivery technologies ex vivo applications synthetic biology cellular biology human health molecular tools biotechnology regulatory affairs drug development sickle cell disease neurological disorders clinical trials biomedical research healthcare drugs & therapeutics gene delivery biogenetic molecular biology life sciences genetic testing therapeutic strategies disease management crispr-based therapies healthcare innovation genome calibration therapeutic development patient-centric solutions ldl cholesterol reduction triglyceride management genetic disease treatment pharmaceutical collaborations transformative healthcare genetic therapeutics healthcare professionals rare diseases personalized medicine biotechnology partnerships crispr technology disease prevention innovative therapeutics healthcare transformation genetic risk management therapeutic pipeline patient outcomes health care health wellness & fitness hospital & health care

SL

Svetlana Lucas Chief Business Officer at Scribe Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Benjamin Oakes in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Scribe Therapeutics.

Benjamin Oakes's Position in the MessageCEO Database

• •Benjamin Oakes is 1 of 1 verified executive contact we track at Scribe Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •63 verified contacts work at research companies in the 120.0 employee range (same size as Scribe Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Benjamin Oakes directly?

Benjamin Oakes's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Scribe Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Benjamin Oakes work for?

Benjamin Oakes is Chief Executive Officer at Scribe Therapeutics, a company in the research sector with 120.0 employees. The company is based in Berkeley, California.

Can I pitch or sell to Benjamin Oakes?

As Chief Executive Officer at Scribe Therapeutics, Benjamin Oakes is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Benjamin Oakes directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Benjamin Oakes in?

Benjamin Oakes works in the research industry as Chief Executive Officer at Scribe Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Benjamin Oakes's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Benjamin Oakes's profile is kept up-to-date with the latest available information.

Last updated: June 26, 2026